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Introduction
Postoperative bile leakage is a common complication 
following upper abdominal surgery. The incidence rates are 
strictly linked with the type of performed surgery, varying 
between 0.9% and 9.0% (1), with rates of mortality reported 
between 8.7% and 39.0% and morbidity ranging between 
22% and 44% (2). The endoscopic approach based on 
endoscopic retrograde cholangiopancreatography (ERCP) 
is widely considered the primary choice to solve bile leaks, 
being in many cases the percutaneous transhepatic biliary 
drainage (PTBD) a useful secondary tool after ERCP failed 
attempts or when an ERCP approach is not feasible (3). 
However, try to obtain a safe biliary access in patients with 
nondilated bile ducts, such as in case of bile leakages, is 
technically more complex of dilated ones, being necessary 
many punctures of liver parenchyma with a higher risk of 
severe bleedings (4). Many studies have shown that PTBD 
can be achieved in patients without dilated bile ducts with 
success rates not far from those with dilated ones (90.5%) (5). 
The initial diagnosis of a bile leakage in many cases follows 
the presence of bile in an abdominal drain or the presence 
of fever with abdominal pain or sepsis with or without 
an evident peritonitis confirmed by an ERCP or a PTC 
(6,7). A precise localization of bile leaks plays a pivotal 
rule to choose the best management, being available many 
imaging modalities ranging from first line ones, like US, to 
more expensive, like CT or MRI (8). All these techniques, 
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chosen in the right clinical setting, are able to give useful 
findings highly suggestive for a bile leak, being the contrast-
enhanced Magnetic Resonance Cholangiography (CE-
MRC) the best one to obtain clear images of an active bile 
leakage or of a cysto-biliary communication. The aim is to 
identify the source of a contrast media (CM) extravasation 
and the precise site of the leakage with associated bile duct 
injury (9). When a clear site of active bile leakage is not 
well shown, invasive techniques such as PTC or ERCP are 
required to show an active CM extravasation from the bile 
ducts. 
Our aim is to describe the role of CE-enhanced MRC 
with T2w-MRC or alone, in the setting of preoperative 
percutaneous management of intra and extrahepatic biliary 
leakages, resuming available techniques, tips, tricks and 
typical findings.
Current algorithm in the detection of biliary 
leakages
The current algorithm to identify a suspected bile leak 
is to perform abdominal US followed by CT and MRC 
when a fluid collection is detected. The common finding 
is the presence of a biloma, characterized on MR by a fluid 
collection sometimes with high T1 and low T2 signal due 
to layering of concentrated extravasated bile (10). T2w-
MRC alone is able to depict a bile leak in the range of 55% 
and 65% (11), whilst CE-MRC with liver specific contrast 
agent can show the source of biliary leak separating fluid 
collections by biliary ones. When a bile leak is suspected, 
a positive diagnosis is made if the contrast agent is visible 
at the same time on late hepatocyte-specific phases in the 
biliary tree and outside the bile ducts. However, must be 
considered that the most of the studies available in literature 
were performed using Mn-DPDP, a liver-specific CM no 
more available in Europe and US markets, respectively from 
2012 and 2003. To date two liver-specific agents are still 
available in the US and Europe: Gd-EOB-DTPA and Gd-
BOPTA, even if according to European Medicine Agency 
recommendations released in 2017, the intravenous linear 
agent Gd-BOPTA should be used in body imaging only 
for liver scans, in those situations where its use is strictly 
advocated, shifting the users “de facto” to perform scans 
with safer and easily available gadoxetic acid (Gd-EOB-
DTPA) remaining Gd-BOPTA as second choice, despite 
lower costs. 
When considering the integration of gadoxetic acid scans 
in a protocol based on T2-weighted (T2w) MRC it should 
be noted that its use is admitted for the detection and 
characterization of focal liver lesions being the depiction of 
bile leaks an “off label” use. In this setting Kul et al. showed 
that the sensitivity, specificity, and accuracy were definitely 
higher when compared with T2W-MRC alone and equal to 
92.9%, 90.5%, and 100%. Alegre Castellanos et al. found 
that Gd-EOB-DTPA boosted bile leaks detection to 100% 
of cases if performed 20 minutes from baseline scans, with 
a highly reliable and advantageous technique over invasive 
strategies (12). Due to the high spatial resolution available 
with Gd-EOB-DTPA-enhanced MRC, it can be considered 
useful to determine the type ductal injury, the presence of 
accessory bile ducts or subvesicular that can be a common 
source of bile leakage (13). Moreover, following European 
Medicine Agency recommendations concerning Gd-
BOPTA and the lack of Mn-DPDP on EU and US markets, 
in this review will be considered only studies performed 
with gadoxetic acid, being easily to be retrieved in clinical 
routine due to the wider availability on the market of the 
latter compound. 
To perform a Gd-EOB-DTPA-enhanced MRC useful to 
plan a prompt leakage management, avoiding more invasive 
or unnecessary tests, is mandatory solve some technical 
issues regarding its pharmacokinetic properties conditioning 
the choice of an adequate scan time to improve biliary tree/
background visualization ratio and the set of an optimal flip 
angle to optimize SNR ratio.
Gadoxetic acid pharmacokinetic properties and 
their impact biliary imaging
Gadolinium hepatocyte-specific CM are cleared by 
glomerular and biliary excretion: in particular for the 
gadoxetic acid the biliary amount is almost 50%, which is 
more than other liver-specific available compounds (14). 
The biliary tree is well shown in the late phase with T1-
weighted gradient echo scans that demonstrate smaller 
peripheral branches in a phase named “excretory phase”. 
The recommended dose for gadoxetic acid is one quarter of 
a typical extracellular CM, corresponding to 0.025 mmol/kg, 
thus requiring more care to obtain an optimal arterial phase 
(AP) reducing its flow rate or through its dilution with 
saline solution. However, the AP protocol is outside of 
the aims of this review, so our attention will be focused on 
factors that impact on the quality of images obtained during 
“excretory/liver specific phase”. Many authors recommend 
to obtain scans from 20 minutes from injection (9), 
because the choice of the optimal time window for “liver 
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specific phase” scans and the presence or not of a clear 
bile leakage, clearly impact on the execution time of a 
Gd-EOB-DTPA-enhanced MRC. Cieszanowski et al. 
in their series performed delayed phase (DP) scans at 
different times after Gd-EOB-DTPA injection (at 20–25, 
90 and 60–180 minutes). They showed the importance of 
60–180 minutes DP, calculating the sensitivity in depicting 
bile leaks for each DP scans, showing a statistically significant 
difference between the sensitivity of 20–25 minutes alone, 
the combined 20–25 and 60–90 minutes or of the complete 
examination carried out by obtaining scans at 20–25, 
60–90 and 150–180 minutes (42.9%, 92.9% and 96.4% 
respectively) (15).
When there is a clinical significant suspicion of bile 
leakage, but liver specific phase can’t demonstrate it, Kul 
et al. suggested to perform supplementary DP scan from 
30 minutes after the Gd-EOB-DTPA injection as long as a 
biliary leakage is found or up to 24 hours, on the basis of the 
radiologist’s opinion. In their series, times of additional scans 
in which leaks were showed ranged from 60–90, 120–150, 
210–240 to 390 minutes (the most delayed phase). In very 
suspicion cases, they indicate that DP scans should be done 
even if the patient has normal total bilirubin levels and liver 
function tests. In fact three patients with bile leaks evidence 
during the DP, had normal laboratory results and no bile 
ducts enlargement. On the other hand patients with biliary 
leakage detected in DP scans had generally higher levels 
of total bilirubin (16). Although more studies are needed, 
some hypothesis are been made to explain the necessary 
use of DP images: a non-specific hepatocyte dysfunction 
could cause high alkaline phosphatase (ALP) and alanine 
aminotransferase (ALT) values or high bilirubin values may 
lead a reduced hepatocyte-uptake of Gd-EOB-DTPA, with 
a delayed visualization of the biliary ducts and potential bile 
leaks (17). Moreover, in case of bile duct obstruction, the 
up-regulation of a multidrug resistance protein, (MRP3) 
could reduce the excretion of Gd-EOB-DTPA in the 
blood mainstream, delaying or preventing the visualization 
of bile ducts and bile leakage (18). In conclusion, even if 
hepatic enzymes and bilirubin values are regular without 
enlarged biliary tree, additional delayed phase images 
(>30 minutes) should be performed if the biliary leakage 
suspicion is significant. 
Common sites of leakage after surgery: what 
interventional radiologists should look for
After cholecystectomy biliary leakage can occur as an 
important complication (19-21) with an incidence ranging 
from 0.2% to 7% for laparoscopic cholecystectomy and 
from 0.1% to 0.5% for open cholecystectomy (19-24). Bile 
leak becomes manifest with one or more of these clinical 
symptoms: abdominal pain (the common one), fever, bilious 
drain, anorexia, malaise, nausea, vomiting and jaundice with 
or without the increase in bilirubin, transaminases and in 
leukocytes (12,16,25). After cholecystectomy, 7 days is the 
medium demonstration time (ranging, usually is 1–15 days, 
but also 30 days after the surgery) (12,16,24), carrying an 
increase in morbidity and mortality, and leading not only to 
a diminution of long-term survival but also a worse quality 
of life (19-21). The use CE-MRCP has been widely used 
over the time even if most of the studies has been based on 
Mangafodipir-trisodium and just some limited number of 
papers that utilize Gd-EOB-DTPA have been published 
(12,24,26,27). 
Gd-EOB-DTPA gives the possibility to perform at 
the same time a dynamic contrast-enhanced MR study 
coupled with delayed liver specific scans, able to depict a 
wide spectrum of complications related to parenchyma, 
vascular structures or bile ducts during the same 
examination (24,28). A retrospective review performed by 
Ratcliffe et al. showed a 100% sensitivity and 98% specificity 
in depicting bile leaks after cholecystectomy by performing 
MRC with iv Gd-EOB-DTPA. The only false positive was 
due by Gd-EOB-DTPA pooling in the cystic duct stump 
misdiagnosed as a bile leak (24). In literature there are 
some case reports which emphasize the role of CE-MRI 
in achieving the correct diagnosis of post-cholecystectomy 
bile leak (29-32). Other authors included cholecystectomy 
patients in their series recommending combined use of 
T2w-MRC and Gadoxetic Acid administration to increase 
the accuracy in depicting the sites of bile leaks (11,12,16). 
For what concerns common extravasation sites following 
hepato-biliary surgery, the extravasated bile may be 
contained in a well-circumscribed collection (biloma) or 
may leak freely into the peritoneal space. The most common 
location for biloma is in the sub hepatic area, however, it 
can be in the intrahepatic or, rarely, in the retroperitoneal 
space (26,33,34). The pooling of contrast media inside 
bilomas can slightly increase their signal intensity or create 
areas of strong hyperintensity on T1-weighted gradient 
echo scans as results of free extravasation outside liver 
parenchyma (26). When patients are in supine position, 
being the CM less dense than bile, it tends to accumulate 
in the anterior part of the fluid collections, following the 
same behavior seen inside gallbladder in healthy patients 
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(26,33). Even if bilomas are found near to the site of a 
bile duct injury, sometimes they could be located far from 
primary damaged site. Serial imaging when contrast starts 
appearing in the biliary tree helps to accurately localize the 
site of the leak before the contrast spreads away (24). Kul 
et al. reported one case of cholecystectomy in which bile 
leak was detected after a delay of 390 minutes after Gd-
EOB-DTPA administration (16,24). However, free or 
collected fluid located near liver or adjacent to a damaged 
bile duct or on the abdominal right side could be strongly 
indicative of a bile leak. In this setting common associated 
injuries are partial or complete bile duct transactions being 
the lack of a bile duct segment on MRCP scans highly 
suspicious for an “injury excision” (16,25,29).
There are several classifications after the first from 
Bismuth used by radiologists to relate the leakage sites 
with CE-MRC (27) and damages after cholecystectomy 
(Strasberg classification, Mattox classification, Hannover 
classification, Stewart-Way classification and McMahon 
classification) (35,36). Bismuth classification is based 
on the distance of biliary strictures from the biliary 
confluence and does not include the entire spectrum of 
bile duct injuries. Instead, the Strasberg classification 
permits the differentiation between bile leakage from 
a small bile duct and serious injuries performed during 
laparoscopic cholecystectomy (35,36). However the 
Strasberg classification does not describe additional vascular 
involvement (29,36). 
Most common causes of bile leaks secondary to 
laparoscopic cholecystectomy include (25): slippage of the 
cystic duct ligature; leak from an accessory or anomalous 
bile duct due to incidental injury related to misidentification 
of biliary anatomy; leaks from the gallbladder bed. The 
most common site for leak is the cystic duct stump and 
usually a small collection develop adjacent to the cystic duct 
remnant or near the cholecystectomy clips. The volume of 
extravasated contrast usually increases in the late sequences 
MR images during the liver specific hepatobiliary phase 
(34,37).
Frequently sites of origin can be subvesical bile ducts, 
common bile duct (CBD), common hepatic duct, liver bed 
or intrahepatic ducts (Figure 1). In particular “subvesical 
bile ducts” (frequently termed incorrectly “ducts of 
Luschka”), should include “any bile duct traversing in 
close contact with the gallbladder fossa”, encompassing 
different types of bile ducts see (Figure 2) (38). The 
variability in anatomic location of subvesical bile ducts 
and their difficult visualization on preoperative imaging 
and during laparoscopy, puts them at risk during hepato-
biliary surgery (38,39), especially when the presence of 
an anatomic abnormality (e.g., an intrahepatic position of 
the gallbladder, or an adherent gallbladder due to chronic 
cholecystitis) makes surgical access difficult and when the 
aberrant subvesicular bile ducts are injured and drained 
directly to the surgical bed (type 3 or 4) (Figure 1) (25,27,40). 
CE-MRC permits  to  depic t  leaks  that  do  not 
communicate with distal biliary ductal system and therefore 
would not likely be detected with ERCP, because the 
latter misses those arising from aberrant bile ducts that 
are disconnected from the main biliary tree (24,26,41-43) 
(Figure 1). 
Biliary leakages could be observed after many other 
surgical procedures, including resection of bile duct tumors, 
repair of biliary tree injuries, liver transplantation, palliative 
surgical approaches for unresectable obstructive tumors, 
pancreaticoduodenectomy for benign and malignant 
neoplasms (Figure 3) and many other surgical procedures 
for chronic pancreatitis and choledocholithiasis in which 
hepaticojejunostomy are performed (Figure 4). The 
latter is usually performed with anastomoses between a 
normal bile duct segment proximal to the site of disease 
and a Roux-en-Y loop of the jejunum (44), without 
cystic duct remnant, although a very small remnant 
may be left in place. Biliary leaks after hepaticojejunal 
anastomosis are rare events, but with potential greater 
morbidity (44), occurring in 0.4% to 8% of the patients, 
depending on the type of procedure (7) with a median 
onset  around day 4 (ranging between 2–13 days) 
after the index operation (45). De Castro et al., showed 
that biliary leaks occurred in 24 of 1,033 patients (2.3%) 
after hepaticojejunostomy with an incidence varying 
from 11% after proximal bile duct resection to 1% after 
a palliative bypass procedure for malignant disease (7). In 
a series of Antolovic et al., among 519 patients analyzed, 
bile leak rates was of 0 to 5% for patients undergoing 
pancreaticoduodenectomy or pancreatectomy and for 
patients undergoing hepaticojejunostomy for repair of 
bile duct injury, while biliary leaks, in the context of liver 
transplantation, occurred in 1–25% of patients (based on 
type of biliary reconstruction, hepaticojejunostomy or 
choledocho-choledochostomy) (45). When dealing with bile 
leak potentially arising from bilioenteric anastomosis great 
advantages were shown introducing contrast-enhancement 
MR Cholangiography (46). Wellner et al. showed different 
sites where search the origin of a bile leak because in the 
setting of bilioenteric anastomosis the source of biliary 
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secretions may occur also from other sites even if injuries of 
the biliary tree outside of the anastomosis region are rare. 
Rather rare are combined leaks of bile and pancreatic juice 
after procedural lacerations of the small bowel after surgery. 
After pancreatoduodenectomy, biliary leakage may also be 
derived from an insufficient pancreatojejunostomy, especially 
when a single jejunal loop is used for bilioenteric and 
pancreatoenteric anastomosis and the distance between the 
pancreatic and the biliary anastomosis is short. Therefore, the 
localization of the bile leak is mandatory before considering 
reoperation or a percutaneous drainage (44).
CE-MRC: what keep in mind
The parameters of the hepatobiliary phase carried in 
the suspicion of a biliary leak could be modified in order 
to optimize biliary tree visualization. For instance, by 
increasing the flip angle the contrast between normal liver 
Figure 1 A 74-year-old man that developed a major biliary leakage at the origin of VI segment biliary branch after elective laparoscopic 
cholecystectomy for biliary lithiasis. Despite a previous percutaneous biliary treatment with a plug to close the transaction, a persistent low-
output loss by abdominal drainage (about 200 mL/day) was reported. (A) CT showing the persistence of a small biloma in the gallbladder 
bed (arrow head). (B) PTC from the PTBD that was previously positioned. No leak was detected. (C,D) Coronal and axial post-contrast 
MRCP showing a small extravasation of Gd-EOB-DPTA (arrow head) near the plug (signal void) from the excluded VI segment branch. 
(E) Coronal T1 weighted MIP image highlighting Gd-EOB-DPTA extravasation and filling a small biloma in the gallbladder bed. Note the 
hyperintensity of the abdominal drainage. (F) PTC from VI excluded segment during IR procedure demonstrating the presence of biliary 
leakage, exactly where it was formerly reported by MRCP. The patient was treated with glue embolization (Glubran and Lipiodol) of the 
biliary branches all around the vascular plug with complete resolution of fistula. PTBD, percutaneous transhepatic biliary drainage.
A B C
D E F
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parenchyma with gadoxetic acid uptake and excretion is 
effectively increased. These effects are mainly due to the 
different pharmacokinetic properties of the Gadoxetic Acid 
involving in the liver, a multidrug resistance-associated 
proteins complex (MRPs) able to excrete an half of the 
contrast media by the liver and an equal percentage by the 
kidneys (47). A key factor to obtain an optimal enhancement 
is a preserved hepatobiliary function: in this setting the 
maximum enhancement of the liver could be obtained in 
20 minutes after contrast media administration. A strategy to 
Figure 2 Types of subvesical bile ducts of Schnelldorfer et al. Type I: superficial variations of right posterior segmental or sectorial duct that 
drains separately into main duct; type II: supernumerary subvesical bile duct (the true Luschka duct) draining into main duct and running 
superficial; type III: hepaticocholecystic bile duct (sectorial duct draining directly into gallbladder); type IV: aberrant subvesical bile duct (grid 
of small bile ducts into the connective capsule/tissue of the gallbladder bed).
I II
III IV
Figure 3 A 55-year-old man who underwent to a Whipple procedure for pancreatic cancer and developed a biliary leakage on biliodigestive 
anastomosis. (A) Post contrast axial MRCP showing small hyperintense biloma (arrow head) near the clips (signal void); (B) post contrast 
coronal MRCP showing extravasation of contrast medium and revealing the location of the leakage; (C) PTC during IR procedure 
demonstrating the presence of biliary leakage, exactly where it was reported by MRCP.
A B C
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maximize the liver to biliary duct visualization ratio is based 
on the use of an increased flip angle, strongly influencing 
the quality of hepatobiliary acquisitions, especially if dealing 
with liver with a preserved hepatobiliary function. In this 
setting clear differences were appreciated when measuring 
the difference in signal obtained from hepatic parenchyma, 
bile duct, and muscles, on hepatobiliary images scanned 
with variable flip angles after 20 minutes from gadoxetic 
acid administration (48). The peak of intensities for biliary 
ducts were shown using a flip angle included between 
35–40°, whilst the higher signal for the “background” 
(e.g., liver healthy parenchyma) was obtained lowering 
the flip angle to interval include between 25–30° (49). 
The importance of the choice of a correct flip angle after 
gadoxetic acid administration to improve the visualization 
of the liver parenchyma or the bile ducts in healthy patients 
was studied with interesting results reporting 25–30° for 
relative liver signal versus muscle ratio and 45° for relative 
bile duct signal vs. liver parenchyma ratio (50). Basing on 
the concept that relatively higher flip angles could improve 
bile duct visualization, were compared late hepatobiliary 
scans obtained with different flip angles ranging between 
10° to 35°, focusing the study on the evaluation of the 
biliary ducts. Better results were obtained in those scans 
performed using a 35° flip angle, which gave the ability 
to depict also smaller and distal biliary branches (51). 
The same author tried to evaluate 3D TSE T2-weighted 
sequences and hepatobiliary T1-weighted scans obtained 
20 minutes after Gadoxetic Acid with a flip angle of 35°. 
The aim was established which technique could be better to 
evaluate the entire biliary tree: late phase scans were able to 
give clearer images with overall higher scores, helping in the 
depiction of biliary variants with a higher level confidence 
that usually obtained with T2 isotropic scans (24). 
Similar results were obtained in another study focused to 
perform a qualitative and quantitative comparison of image 
quality in depicting differences among first-, second-, 
and third-order intrahepatic ducts using scans obtained 
with different flip angles. Best results in terms of clarity 
of bile ducts visualization, background signal suppression, 
and overall image quality were significantly higher for 
flip angle of 25° and 40°, especially if compared with 12° 
set during scans carried for focal liver lesion detection 
and characterization. Same results were obtained for 
quantitative measurement in Signal to Noise Ratios and 
Contrast to Noise Ratios of the common bile duct that 
were significantly higher for flip angle of 25° and 40° than 
for 12° (25). Another interesting factor to be considered, 
when using hepatobiliary T1-weighted acquisitions 
obtained 20 minutes after gadoxetic acid administration 
concerns the choice of “breath hold” scan or a high-
resolution navigated one based on optimized T1-weighted 
pulse. An interesting paper explored the difference 
between two different acquisitions using a high spatial 
A B C
Figure 4 A 27-year-old woman who underwent cholecystectomy and resection of a large choledochocele and developed a biliary leakage on 
biliodigestive anastomosis. (A,B) post contrast coronal MRCP showing extravasation of contrast medium from the posterior branch used for 
the biliodigestive anastomosis; note the hyperintensity of the biliary drainage (C) PTC during IR procedure demonstrating the presence of 
biliary leakage, consistent with MRCP report.
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resolution T1-weighted sequence of 1.2×1.4×1.8 mm3 
interpolated to 0.7×0.7×0.9 mm3 with navigator-gating 
enabled acquired in approximately 5 minutes of free-
breathing and multiple breath-held acquisitions performed 
at flip angles varying between 15° and 45° to optimize 
T1-weighting. The aim was to assess the image quality 
and biliary excretion and results showed that optimal 
hepatobiliary imaging occurred at 15–25 minutes using a 
40° flip angle resulting in an excellent image quality and 
visualization of biliary excretion.
Special considerations: what to do in cirrhotic 
liver
The main theory concerning regarding Gadoxetic Acid 
is that liver specific uptake is based on the organic anion-
transporting polypeptide functions of OATP8 (52). In 
the setting of impaired liver function it is reduced with an 
overall loss of effective uptake corresponding to a reduced 
enhancement in the liver specific phase, when liver to 
muscle ratio is considered. This phenomenon is more 
prominent when comparing patients with different Child-
Pugh class (e.g., A and C) even if there is a lack of data 
concerning a quantitative difference in the enhancement 
of cirrhotic with Child-Pugh class A or B disease (53). 
Some authors suggested to compensate the lack of 
enhancement by doubling the dose for Child-Pugh class 
B patients from 0.025 to 0.05 mmol/kg of body weight, 
prolonging the liver specific phase over conventional 
20 minutes after CM injection, a strategy strictly needed, 
when dealing with bile leakages (54). Must be remembered 
that in a model for end-stage liver disease with a score 
≥11, 76% of examinations were judged not sufficient for 
anatomical diagnosis of biliary tree after 180 minutes (28). 
Although in the setting of bile leakages high bilirubin levels 
is a not frequent condition, their values ≥1.8 mg/dL or 
160 μmol/L are described as a factor able to dramatically 
reduce the image quality (28). The uptake of gadoxetic 
acid can depend also by the presence of arterial-portal and 
portal-systemic shunts able to decrease the overall liver 
blood flow, with consequential GD-EOB-DTPA liver 
retention (54). Less know causes of a lack in enhancement 
in liver specific phase, can include severe steatosis, severe 
fibrosis and iron overload (55,56).
Conclusions
Despite limits of CE-MRC include its high cost and the 
delay in depicting the bile duct in patients with hepatobiliary 
dysfunction, the Gd-EOB-DTPA-enhanced MR imaging 
protocol ,  when combined with T2-weighted MR 
cholangiography can definitely improve the visualization 
of biliary system and bile leaks. This approach must be 
included in the planning of any radiologic interventional 
procedure aimed to treat biliary injuries, particularly post-
surgical leaks. However, its clinical applications must be 
widely investigated to clearly define the best technique 
to better visualize smaller leakages and more studies are 
needed to standardize the technique to perform Gd-EOB-
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